Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE3.7300
- TODAY'S CHANGE (%)0.2800 (8.1159%)
- Bid / Lots3.5000/ 1
- Ask / Lots4.5000/ 3
- Open / Previous Close3.4600 / 3.4500
- Day Range
- 52 Week Range
- Volume2,003,099
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 16522 | 3.525 |
| 09:34 ET | 198849 | 3.5 |
| 09:36 ET | 15577 | 3.5095 |
| 09:38 ET | 14100 | 3.505 |
| 09:39 ET | 5000 | 3.5 |
| 09:41 ET | 5400 | 3.47 |
| 09:43 ET | 345 | 3.4787 |
| 09:45 ET | 4239 | 3.4695 |
| 09:48 ET | 7192 | 3.48 |
| 09:50 ET | 2299 | 3.49 |
| 09:52 ET | 201800 | 3.495 |
| 09:54 ET | 400 | 3.49 |
| 09:56 ET | 2575 | 3.49 |
| 09:57 ET | 6577 | 3.485 |
| 09:59 ET | 38937 | 3.47 |
| 10:01 ET | 7232 | 3.465 |
| 10:03 ET | 3603 | 3.475 |
| 10:06 ET | 1331 | 3.495 |
| 10:08 ET | 154718 | 3.5 |
| 10:10 ET | 80839 | 3.485 |
| 10:12 ET | 1955 | 3.485 |
| 10:14 ET | 637 | 3.485 |
| 10:15 ET | 770 | 3.485 |
| 10:17 ET | 2172 | 3.485 |
| 10:19 ET | 1686 | 3.495 |
| 10:21 ET | 6987 | 3.5001 |
| 10:24 ET | 533 | 3.49 |
| 10:26 ET | 1540 | 3.49 |
| 10:28 ET | 8350 | 3.49 |
| 10:30 ET | 1400 | 3.49 |
| 10:32 ET | 1500 | 3.49 |
| 10:33 ET | 1537 | 3.495 |
| 10:35 ET | 13274 | 3.495 |
| 10:37 ET | 1200 | 3.49 |
| 10:39 ET | 737 | 3.495 |
| 10:42 ET | 2713 | 3.495 |
| 10:44 ET | 17063 | 3.5 |
| 10:46 ET | 1200 | 3.4957 |
| 10:48 ET | 86854 | 3.49 |
| 10:50 ET | 8792 | 3.5 |
| 10:51 ET | 201256 | 3.5 |
| 10:53 ET | 14550 | 3.5 |
| 10:55 ET | 23615 | 3.5101 |
| 10:57 ET | 44912 | 3.56 |
| 11:00 ET | 12011 | 3.58 |
| 11:02 ET | 10690 | 3.58 |
| 11:04 ET | 6800 | 3.575 |
| 11:06 ET | 1500 | 3.57 |
| 11:08 ET | 100 | 3.575 |
| 11:09 ET | 1700 | 3.575 |
| 11:11 ET | 6651 | 3.54 |
| 11:13 ET | 6867 | 3.52 |
| 11:15 ET | 8968 | 3.515 |
| 11:18 ET | 1034 | 3.515 |
| 11:20 ET | 200 | 3.52 |
| 11:22 ET | 100 | 3.52 |
| 11:26 ET | 1462 | 3.525 |
| 11:29 ET | 700 | 3.515 |
| 11:31 ET | 3100 | 3.545 |
| 11:33 ET | 100 | 3.545 |
| 11:38 ET | 1480 | 3.545 |
| 11:40 ET | 200 | 3.545 |
| 11:42 ET | 6490 | 3.525 |
| 11:44 ET | 133 | 3.525 |
| 11:45 ET | 426 | 3.515 |
| 11:47 ET | 300 | 3.515 |
| 11:49 ET | 1895 | 3.52 |
| 11:51 ET | 2145 | 3.51 |
| 11:54 ET | 100 | 3.515 |
| 11:56 ET | 1995 | 3.515 |
| 11:58 ET | 100 | 3.51 |
| 12:00 ET | 1735 | 3.515 |
| 12:02 ET | 300 | 3.515 |
| 12:03 ET | 100 | 3.51 |
| 12:05 ET | 1655 | 3.52 |
| 12:07 ET | 6049 | 3.53 |
| 12:09 ET | 9766 | 3.56 |
| 12:14 ET | 1381 | 3.57 |
| 12:16 ET | 1500 | 3.5719 |
| 12:18 ET | 925 | 3.585 |
| 12:20 ET | 300 | 3.59 |
| 12:21 ET | 1559 | 3.59 |
| 12:23 ET | 3792 | 3.585 |
| 12:25 ET | 2414 | 3.5959 |
| 12:27 ET | 20148 | 3.59 |
| 12:30 ET | 1978 | 3.5988 |
| 12:32 ET | 706 | 3.595 |
| 12:36 ET | 117 | 3.595 |
| 12:38 ET | 200 | 3.595 |
| 12:39 ET | 200 | 3.6 |
| 12:41 ET | 400 | 3.595 |
| 12:43 ET | 288 | 3.595 |
| 12:45 ET | 33372 | 3.66 |
| 12:48 ET | 8857 | 3.64 |
| 12:50 ET | 8216 | 3.655 |
| 12:52 ET | 7244 | 3.645 |
| 12:54 ET | 1758 | 3.64 |
| 12:56 ET | 6212 | 3.635 |
| 12:57 ET | 886 | 3.635 |
| 12:59 ET | 200 | 3.635 |
| 01:01 ET | 500 | 3.635 |
| 01:03 ET | 6995 | 3.63 |
| 01:06 ET | 800 | 3.63 |
| 01:08 ET | 1341 | 3.63 |
| 01:10 ET | 7036 | 3.63 |
| 01:12 ET | 2075 | 3.625 |
| 01:14 ET | 960 | 3.625 |
| 01:15 ET | 210 | 3.625 |
| 01:17 ET | 2123 | 3.6258 |
| 01:19 ET | 200 | 3.63 |
| 01:21 ET | 800 | 3.635 |
| 01:24 ET | 725 | 3.635 |
| 01:26 ET | 900 | 3.64 |
| 01:28 ET | 900 | 3.64 |
| 01:30 ET | 500 | 3.64 |
| 01:32 ET | 500 | 3.64 |
| 01:33 ET | 3575 | 3.65 |
| 01:35 ET | 438 | 3.65 |
| 01:37 ET | 338 | 3.645 |
| 01:39 ET | 200 | 3.65 |
| 01:42 ET | 400 | 3.65 |
| 01:44 ET | 2498 | 3.64 |
| 01:46 ET | 3557 | 3.6301 |
| 01:48 ET | 7765 | 3.635 |
| 01:50 ET | 8234 | 3.645 |
| 01:51 ET | 3864 | 3.64 |
| 01:53 ET | 2814 | 3.64 |
| 01:55 ET | 363 | 3.645 |
| 01:57 ET | 100 | 3.645 |
| 02:00 ET | 100 | 3.645 |
| 02:02 ET | 1359 | 3.64 |
| 02:04 ET | 3438 | 3.66 |
| 02:06 ET | 508 | 3.67 |
| 02:08 ET | 2587 | 3.675 |
| 02:09 ET | 700 | 3.68 |
| 02:11 ET | 500 | 3.68 |
| 02:13 ET | 500 | 3.68 |
| 02:15 ET | 400 | 3.68 |
| 02:18 ET | 400 | 3.68 |
| 02:20 ET | 200 | 3.68 |
| 02:22 ET | 868 | 3.68 |
| 02:24 ET | 300 | 3.68 |
| 02:26 ET | 496 | 3.68 |
| 02:27 ET | 10110 | 3.67 |
| 02:29 ET | 825 | 3.665 |
| 02:31 ET | 4688 | 3.655 |
| 02:33 ET | 865 | 3.655 |
| 02:36 ET | 2009 | 3.645 |
| 02:38 ET | 1303 | 3.645 |
| 02:40 ET | 2734 | 3.64 |
| 02:42 ET | 1000 | 3.64 |
| 02:44 ET | 200 | 3.635 |
| 02:45 ET | 5783 | 3.62 |
| 02:47 ET | 12714 | 3.64 |
| 02:49 ET | 2577 | 3.635 |
| 02:51 ET | 1787 | 3.635 |
| 02:54 ET | 200 | 3.635 |
| 02:56 ET | 1562 | 3.635 |
| 02:58 ET | 600 | 3.64 |
| 03:00 ET | 2164 | 3.63 |
| 03:02 ET | 800 | 3.63 |
| 03:03 ET | 1424 | 3.625 |
| 03:05 ET | 1125 | 3.63 |
| 03:07 ET | 1552 | 3.625 |
| 03:09 ET | 11776 | 3.61 |
| 03:12 ET | 1493 | 3.615 |
| 03:14 ET | 1936 | 3.605 |
| 03:16 ET | 377 | 3.605 |
| 03:18 ET | 1896 | 3.605 |
| 03:20 ET | 632 | 3.605 |
| 03:21 ET | 5646 | 3.6 |
| 03:23 ET | 1989 | 3.605 |
| 03:25 ET | 1334 | 3.61 |
| 03:27 ET | 1783 | 3.61 |
| 03:30 ET | 295 | 3.605 |
| 03:32 ET | 1233 | 3.605 |
| 03:34 ET | 15866 | 3.635 |
| 03:36 ET | 5581 | 3.615 |
| 03:38 ET | 909 | 3.615 |
| 03:39 ET | 2554 | 3.625 |
| 03:41 ET | 3651 | 3.635 |
| 03:43 ET | 1984 | 3.635 |
| 03:45 ET | 1976 | 3.635 |
| 03:48 ET | 5290 | 3.645 |
| 03:50 ET | 20094 | 3.665 |
| 03:52 ET | 24600 | 3.685 |
| 03:54 ET | 29569 | 3.72 |
| 03:56 ET | 38623 | 3.72 |
| 03:57 ET | 52514 | 3.715 |
| 03:59 ET | 119349 | 3.73 |
Jun 17, 2024
DJ Autolus Therapeutics Price Target Maintained With a $9.00/Share by Needham, from 6:02AM ET on Monday Jun 17, 2024 by Dow Jones
6:02AM ET on Monday Jun 17, 2024 by Dow Jones
Jun 14, 2024
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress, from 7:00AM ET on Friday Jun 14, 2024 by Dow Jones
7:00AM ET on Friday Jun 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 917.8M | -3.1x | --- |
Cullinan Therapeutics Inc | 932.5M | -5.2x | --- |
Tyra Biosciences Inc | 898.4M | -10.6x | --- |
ARS Pharmaceuticals Inc | 881.7M | -18.2x | --- |
Pharvaris NV | 896.0M | -6.8x | --- |
Rapport Therapeutics Inc | 875.3M | -16.7x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $917.8M |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.11 |
EPS | $-1.21 |
Book Value | --- |
P/E Ratio | -3.1x |
Price/Sales (TTM) | 87.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,670.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
